31 Deferasirox should not be combined with other iron chelation therapies Monitoring Patients Taking Deferasirox Item to MonitorFrequency Blood intakeOngoing Serum ferritinMonthly with dose adjustment based on 3– to 6-month trends Renal function testsIn duplicate before initiating deferasirox therapy, weekly during the first month; monthly thereafter Liver function testsMonthly during therapy Auditory and ophthalmic testing Before the start of deferasirox therapy; annually thereafter Exjade (deferasirox).
{}